A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.

Cannizzaro DN, Naughton LF, Freeman MZ, Martin L, Bennett CL, Bove C

Open source

DOI
10.3390/medicina57121371
Published
2021 Dec 16
Container
Medicina (Kaunas, Lithuania)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina57121371,
  title = {A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.},
  author = {Cannizzaro DN and Naughton LF and Freeman MZ and Martin L and Bennett CL and Bove C},
  year = {2021},
  journal = {Medicina (Kaunas, Lithuania)},
  doi = {10.3390/medicina57121371},
  url = {https://doi.org/10.3390/medicina57121371}
}

RIS

TY  - JOUR
TI  - A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.
AU  - Cannizzaro DN
AU  - Naughton LF
AU  - Freeman MZ
AU  - Martin L
AU  - Bennett CL
AU  - Bove C
PY  - 2021
JO  - Medicina (Kaunas, Lithuania)
DO  - 10.3390/medicina57121371
UR  - https://doi.org/10.3390/medicina57121371
ER  - 

APA

DN, C., LF, N., MZ, F., L, M., CL, B., & C, B. (2021). A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina57121371

Source records